Endocrinology Practice Questions

Q: In evaluating the effectiveness of a new drug for treating hyperthyroidism, which laboratory finding would be the most indicative of drug efficacy?

Decreased serum T3 and T4 levels. ***Decreased serum T3 and T4 levels*** - **Hyperthyroidism** is characterized by excessively high levels of thyroid hormones, primarily **T3** and **T4** [1]. - A drug's efficacy in treating hyperthyroidism would be directly reflected by a **reduction** in these elevated hormone levels, moving them towards the normal range. *Increased serum TSH levels* - In primary hyperthyroidism, the high levels of T3 and T4 typically **suppress** the release of **TSH** from the pituitary gland through negative feedback [1], [2]. - An **increase** in TSH, especially trending towards the normal range, combined with decreasing thyroid hormones, would suggest the thyroid gland is less hyperactive and TSH secretion is beginning to normalize in response. This would be a **secondary indicator** of drug efficacy. *Increased serum T3 and T4 levels* - An **increase** in serum T3 and T4 levels would indicate a **worsening** of hyperthyroidism or a lack of drug efficacy, as these are the hormones that are overproduced in this condition. - This finding would suggest the treatment is ineffective or that the dose is insufficient. *Decreased serum TSH levels* - **Decreased TSH levels** are characteristic of untreated hyperthyroidism due to negative feedback on the pituitary [1]. - If TSH levels remain low or decrease further, it suggests that the thyroid hormone levels are still high, and the drug is **not effectively reducing** thyroid hormone production.

Q: What is the most common cause of hypothyroidism in areas with adequate iodine intake?

Hashimoto's thyroiditis. ***Hashimoto's thyroiditis*** - This is an **autoimmune disease** where the body's immune system attacks the thyroid gland, leading to chronic inflammation and eventual underproduction of thyroid hormones [1]. - It is the **most common cause of hypothyroidism** in regions with sufficient iodine intake [1]. *Iodine deficiency* - While iodine deficiency is the most common cause of hypothyroidism worldwide, the question specifically states "in areas with **adequate iodine intake**." - Lack of iodine hinders the thyroid's ability to produce thyroid hormones but is preventable through dietary supplementation. *Thyroidectomy* - This is the **surgical removal of all or part of the thyroid gland**, which can certainly lead to hypothyroidism if not enough thyroid tissue remains or if replacement therapy is inadequate. - However, it is an iatrogenic (medically induced) cause, not a naturally occurring disease process, and less common than autoimmune thyroiditis. *Pituitary adenoma* - A pituitary adenoma can cause **secondary hypothyroidism** by interfering with the pituitary gland's production of **Thyroid-Stimulating Hormone (TSH)** [1]. - This is a less common cause of hypothyroidism compared to primary thyroid disorders and is typically identified by additional symptoms related to pituitary dysfunction.

Q: Which clinical finding best supports the diagnosis of primary hyperparathyroidism?

High serum calcium. High serum calcium - **Primary hyperparathyroidism** is characterized by excessive secretion of **parathyroid hormone (PTH)**, which leads to increased calcium reabsorption from bone and kidneys, resulting in **hypercalcemia** [1]. [4] - This is the most consistent and defining biochemical hallmark of the disease [2]. *Low serum calcium* - **Hypocalcemia** is indicative of conditions like **hypoparathyroidism** or vitamin D deficiency, where PTH levels are usually low or ineffective [3]. - It directly contradicts the overproduction of PTH seen in primary hyperparathyroidism, which aims to raise calcium levels. *High serum phosphorus* - In primary hyperparathyroidism, elevated PTH causes increased renal phosphate excretion, leading to **low or normal serum phosphorus** levels, not high [1]. [4] - **Hyperphosphatemia** is more characteristic of conditions like renal failure or hypoparathyroidism [3]. *Low serum magnesium* - While electrolyte imbalances can occur, **hypomagnesemia** is not a primary diagnostic criterion for hyperparathyroidism. - Severe hypomagnesemia can sometimes paradoxically reduce PTH secretion or its action, but it's not a direct consequence or diagnostic marker of primary hyperparathyroidism [3].

Q: In the context of Type 1 diabetes, which complication is primarily influenced by poor glycemic control?

Diabetic ketoacidosis. ***Diabetic ketoacidosis*** - **Diabetic ketoacidosis (DKA)** is a life-threatening complication of **Type 1 diabetes** directly caused by severe **insulin deficiency** and **hyperglycemia** (poor glycemic control), leading to the body breaking down fat for energy and producing ketones [2]. - The lack of insulin prevents glucose from entering cells, escalating blood glucose levels and triggering the characteristic symptoms of **DKA** such as **acidosis**, **dehydration**, and **electrolyte imbalance** [3]. *Hypothyroidism* - **Hypothyroidism** is an **autoimmune condition** more frequently associated with Type 1 diabetes, but its onset and severity are not directly or primarily influenced by **glycemic control** [1]. - It results from the immune system attacking the **thyroid gland**, leading to reduced thyroid hormone production, independent of blood glucose levels. *Cushing's syndrome* - **Cushing's syndrome** is an **endocrine disorder** caused by prolonged exposure to high levels of **cortisol**, often due to a pituitary tumor or adrenal gland issues. - This condition can **induce hyperglycemia** and make glycemic control difficult, but it is not a direct complication of poor glycemic control in Type 1 diabetes; rather, it is a separate primary disorder. *Addison's disease* - **Addison's disease** is a rare, **autoimmune disorder** where the **adrenal glands** produce insufficient amounts of **cortisol and aldosterone**. It is sometimes seen in conjunction with Type 1 diabetes as part of a polyglandular autoimmune syndrome. - While it can be associated with Type 1 diabetes due to shared autoimmune mechanisms, it is an independent endocrine disorder and its development or progression is not linked to the patient's **glycemic control**.

Q: What is the most common cause of secondary hyperparathyroidism?

Chronic kidney disease. ***Chronic kidney disease*** - **Chronic kidney disease (CKD)** is the most common cause of secondary hyperparathyroidism due to impaired calcitriol synthesis and phosphate retention, leading to **hypocalcemia** [1], [3]. - The reduced GFR in CKD prevents efficient phosphate excretion, causing **hyperphosphatemia**, which directly stimulates PTH secretion and exacerbates hypocalcemia [3]. *Vitamin D deficiency* - While vitamin D deficiency can cause secondary hyperparathyroidism by leading to hypocalcemia, it is generally considered less common than CKD as the primary cause globally [2]. - Insufficient vitamin D impairs intestinal calcium absorption, triggering increased **PTH secretion** to maintain serum calcium levels [2], [4]. *Parathyroid adenoma* - A **parathyroid adenoma** is the most common cause of **primary hyperparathyroidism**, characterized by autonomous overproduction of PTH, leading to **hypercalcemia** [1]. - This condition involves a tumor of the parathyroid gland itself, differentiating it from secondary forms where PTH elevation is compensatory [1]. *Calcium deficiency* - While prolonged and severe dietary **calcium deficiency** can lead to secondary hyperparathyroidism due to chronic hypocalcemia, it is a less frequent cause compared to chronic kidney disease. - The body attempts to compensate for low calcium intake by increasing **PTH secretion** to mobilize calcium from bones and increase renal reabsorption [4].

Q: A 45-year-old female presents with weight gain, muscle weakness, and easy bruising. Laboratory tests show elevated cortisol levels. What is the most likely diagnosis?

Cushing's syndrome. ***Cushing's syndrome*** - **Weight gain**, **muscle weakness**, and **easy bruising** are classic signs of Cushing's syndrome [2], caused by prolonged exposure to high levels of cortisol. - **Elevated cortisol levels** confirmed by laboratory tests are diagnostic for Cushing's syndrome [1]. *Addison's disease* - This condition is characterized by **adrenal insufficiency**, leading to *low* cortisol levels, not elevated ones. - Clinical features often include **hyperpigmentation**, fatigue, weight loss, and hypotension, which are contrary to the symptoms described. *Hypothyroidism* - Although **weight gain** and **fatigue** can be symptoms, muscle weakness to the degree causing easy bruising is less typical. - It involves low thyroid hormone levels, not elevated cortisol. *Pheochromocytoma* - This is a tumor of the adrenal medulla that secretes **catecholamines**, leading to symptoms like episodes of hypertension, palpitations, and sweating. - It does not primarily cause elevated cortisol levels or the specific constellation of symptoms described.

Q: A 30-year-old female with Graves' disease presents with worsening eye symptoms, including double vision and proptosis. What is the underlying mechanism of her eye symptoms?

Autoimmune-mediated inflammation of extraocular muscles. ***Autoimmune-mediated inflammation of extraocular muscles*** - **Graves' ophthalmopathy** is characterized by an autoimmune response, where **antibodies** mistakenly target receptors on fibrocytes in the **extraocular muscles** and periorbital tissues [1], [2]. - This leads to **inflammation**, swelling, and accumulation of **glycosaminoglycans**, causing muscle enlargement, **proptosis**, and restricted eye movement (leading to diplopia) [2], [3]. *Excess thyroid hormone production* - While **Graves' disease** is characterized by **excess thyroid hormone**, the eye symptoms (**Graves' ophthalmopathy**) are a separate, though often co-occurring, autoimmune process [1]. - The severity of ophthalmopathy does not always correlate with the level of **thyroid hormone** [1]. *Inflammation of the optic nerve* - **Optic neuritis** can occur with other autoimmune diseases (e.g., multiple sclerosis) but is not the primary mechanism behind the common eye symptoms of **Graves' ophthalmopathy** like proptosis and double vision. - While severe proptosis can indirectly lead to **optic neuropathy** due to compression, it's a secondary complication, not the initial cause of the orbital symptoms [3]. *Increased intraocular pressure* - **Increased intraocular pressure** typically causes **glaucoma** and primarily affects the optic nerve's structure and function, leading to visual field defects. - It does not directly cause the **proptosis** or the **restrictive extraocular myopathy** that leads to diplopia seen in **Graves' ophthalmopathy**.

Q: A 38-year-old woman presents with visual field defects and galactorrhea. An MRI reveals a pituitary mass. Which class of drugs would be most appropriate for treating this condition?

Dopamine agonist. ***Dopamine agonist*** - **Galactorrhea** suggests hyperprolactinemia, often caused by a **prolactinoma** [3] (a type of pituitary adenoma), which can be effectively treated with dopamine agonists [1]. - Dopamine agonists (e.g., **bromocriptine, cabergoline**) mimic dopamine's inhibitory effect on prolactin secretion, leading to a reduction in prolactin levels and tumor shrinkage, thus resolving visual field defects [1],[2]. *Beta-blocker* - **Beta-blockers** are primarily used to treat conditions like hypertension, angina, and anxiety, and do not directly address pituitary tumors or hyperprolactinemia. - They work by blocking the effects of adrenaline and do not influence prolactin secretion or tumor size. *Serotonin antagonist* - **Serotonin antagonists** are used in various conditions, including migraine prophylaxis and treatment of carcinoid syndrome, but they have no role in managing pituitary masses or high prolactin levels. - These drugs target serotonin receptors and do not affect dopamine pathways relevant to prolactin regulation. *Acetylcholinesterase inhibitor* - **Acetylcholinesterase inhibitors** are used to treat conditions like Alzheimer's disease and myasthenia gravis by increasing acetylcholine levels in the brain. - They are not indicated for the treatment of pituitary tumors or hyperprolactinemia, as their mechanism of action is unrelated to prolactin regulation.

Question 1

In evaluating the effectiveness of a new drug for treating hyperthyroidism, which laboratory finding would be the most indicative of drug efficacy?

Accepted Answer

Decreased serum T3 and T4 levels

Answer

Increased serum TSH levels

Answer

Increased serum T3 and T4 levels

Answer

Decreased serum TSH levels

Question 2

Which treatment is preferred for managing Graves' disease considering the risks of recurrence and complications?

Accepted Answer

Radioactive iodine is preferred due to its minimal invasiveness and effectiveness in treating hyperthyroidism.

Answer

Surgery is a definitive treatment but has higher complication rates.

Answer

Combination therapy with both treatments may provide better outcomes.

Answer

Radioactive iodine is not recommended due to potential recurrence.

Question 3

What is the most common cause of hypothyroidism in areas with adequate iodine intake?

Accepted Answer

Hashimoto's thyroiditis

Answer

Iodine deficiency

Answer

Thyroidectomy

Answer

Pituitary adenoma

Question 4

Which clinical finding best supports the diagnosis of primary hyperparathyroidism?

Accepted Answer

High serum calcium

Answer

Low serum calcium

Answer

High serum phosphorus

Answer

Low serum magnesium

Question 5

In the context of Type 1 diabetes, which complication is primarily influenced by poor glycemic control?

Accepted Answer

Diabetic ketoacidosis

Answer

Hypothyroidism

Answer

Cushing's syndrome

Answer

Addison's disease

Question 6

What is the most common cause of secondary hyperparathyroidism?

Accepted Answer

Chronic kidney disease

Answer

Vitamin D deficiency

Answer

Parathyroid adenoma

Answer

Calcium deficiency

Question 7

What is the recommended approach for managing subclinical hypothyroidism in elderly patients?

Accepted Answer

Management should be individualized based on cardiovascular risk factors.

Answer

Early treatment is preferred to prevent cardiovascular complications.

Answer

Observation is sufficient as progression to overt hypothyroidism is rare.

Answer

Treatment should only be initiated if TSH levels exceed 10 mIU/L.

Question 8

A 45-year-old female presents with weight gain, muscle weakness, and easy bruising. Laboratory tests show elevated cortisol levels. What is the most likely diagnosis?

Accepted Answer

Cushing's syndrome

Answer

Addison's disease

Answer

Hypothyroidism

Answer

Pheochromocytoma

Question 9

A 30-year-old female with Graves' disease presents with worsening eye symptoms, including double vision and proptosis. What is the underlying mechanism of her eye symptoms?

Accepted Answer

Autoimmune-mediated inflammation of extraocular muscles

Answer

Excess thyroid hormone production

Answer

Inflammation of the optic nerve

Answer

Increased intraocular pressure

Question 10

A 38-year-old woman presents with visual field defects and galactorrhea. An MRI reveals a pituitary mass. Which class of drugs would be most appropriate for treating this condition?

Accepted Answer

Dopamine agonist

Answer

Beta-blocker

Answer

Serotonin antagonist

Answer

Acetylcholinesterase inhibitor

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?